TNGX Free Cash Flow
-$144.27MTTM · USD
Period ending:
TNGX FY Free Cash FlowUSD
$68.97M-$139.93M
2019-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
TNGX free cash flow history
Operating cash flow minus capital expenditures. The available annual fiscal periods series contains 7 observations from Dec 31, 2019 to Dec 31, 2025.
| Period ending | Free Cash Flow (USD) |
|---|---|
| -139,934,000 | |
| -132,255,000 | |
| -119,508,000 | |
| -116,772,000 | |
| -61,364,000 | |
| 68,968,000 | |
| -26,620,000 |
Compare free cash flow
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) free cash flow
- Bridgebio Pharma Inc (BBIO) free cash flow
- Brightspring Health Services Inc (BTSG) free cash flow
- Madrigal Pharmaceuticals Inc (MDGL) free cash flow
- Ensign Group Inc (ENSG) free cash flow
- Glaukos Corp (GKOS) free cash flow
- Vaxcyte Inc (PCVX) free cash flow
- Krystal Biotech Inc (KRYS) free cash flow
All TNGX financial metrics · TNGX stock overview · How to interpret financial metrics
